MSSNG is a groundbreaking collaboration between Autism Speaks, Verily and Toronto’s Hospital for Sick children to create the world’s largest genomic database on autism. The completed sequencing of the first 5,000 whole genomes has led to groundbreaking discoveries about subtypes of autism and their associated medical conditions.
This session will discuss how the MSSNG genome project is being used to identify genetic causes of and to give leads to the biology of autism subgroups. Further, the panel will explore how pre-clinical animal models can be used to identify potential therapeutics for well-defined genetic targets and eventually newly-defined (SYNGAP1, ADNP, WDR26) genetic syndromes associated with autism.
Ability Level: All
Session ID: 20928